Literature DB >> 27936923

Evaluation of the automated Becton Dickinson MAX real-time PCR platform for detection of Pneumocystis jirovecii.

Jung-Yien Chien1, Chia-Jung Liu1, Pei-Chien Chuang2, Tai-Fen Lee2, Yu-Tsung Huang3,4, Chun-Hsing Liao3, Chien-Ching Hung1, Wan-Huei Sheng1, Chong-Jen Yu1, Po-Ren Hsueh1,2.   

Abstract

AIM: We evaluated the performance of the automated quantitative BD MAX (Becton Dickinson) real-time PCR platform for detecting Pneumocystis jirovecii. MATERIALS &
METHODS: A total of 34 retrospective and 137 prospective samples were included.
RESULTS: Retrospectively, all (100%) positive samples were correctly detected by this platform compared with a nested PCR. Among prospective samples, the overall sensitivity, specificity, positive likelihood ratio and negative likelihood ratio were 92.6%, 94.5%, 17.0 and 0.1, respectively. All bronchoalveolar lavage fluid (BALF)/bronchial washing samples were correctly identified by this platform. Samples from patients with colonization had significantly higher median amplification cycle threshold values than patients with P. jirovecii pneumonia.
CONCLUSION: The quantitative BD MAX real-time PCR is a rapid and highly sensitive modality for detecting P. jirovecii, especially in samples from bronchoalveolar lavage fluid/bronchial washing fluid.

Entities:  

Keywords:  MSG; P. jirovecii pneumonia; PCR; Pneumocystis jirovecii; major surface glycoprotein; mtLSU PCR; nested mitochondrial large subunit (mtLSU) PCR; real-time PCR

Mesh:

Year:  2016        PMID: 27936923     DOI: 10.2217/fmb-2016-0115

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  5 in total

1.  Comparative Evaluation Between the RealStar Pneumocystis jirovecii PCR Kit and the AmpliSens Pneumocystis jirovecii (carinii)-FRT PCR Kit for Detecting P. jirovecii in Non-HIV Immunocompromised Patients.

Authors:  Hee Jae Huh; Kyoung Ree Lim; Chang Seok Ki; Kyungmin Huh; Hyang Jin Shim; Dong Joon Song; Yae Jean Kim; Doo Ryeon Chung; Nam Yong Lee
Journal:  Ann Lab Med       Date:  2019-03       Impact factor: 3.464

Review 2.  Recent Advances and Novel Approaches in Laboratory-Based Diagnostic Mycology.

Authors:  Lewis P White; Jessica S Price
Journal:  J Fungi (Basel)       Date:  2021-01-11

3.  Epidemiological and clinical characteristics of immunocompromised patients infected with Pneumocystis jirovecii in a twelve-year retrospective study from Norway.

Authors:  Stine Grønseth; Tormod Rogne; Raisa Hannula; Bjørn Olav Åsvold; Jan Egil Afset; Jan Kristian Damås
Journal:  BMC Infect Dis       Date:  2021-07-07       Impact factor: 3.090

4.  Pneumocystis PCR: It Is Time to Make PCR the Test of Choice.

Authors:  Laura Doyle; Sherilynn Vogel; Gary W Procop
Journal:  Open Forum Infect Dis       Date:  2017-09-02       Impact factor: 3.835

5.  Is It Possible to Differentiate Pneumocystis jirovecii Pneumonia and Colonization in the Immunocompromised Patients with Pneumonia?

Authors:  Yudy A Aguilar; Zulma Vanessa Rueda; María Angélica Maya; Cristian Vera; Jenniffer Rodiño; Carlos Muskus; Lázaro A Vélez
Journal:  J Fungi (Basel)       Date:  2021-12-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.